PUBLISHER: The Business Research Company | PRODUCT CODE: 1484961
PUBLISHER: The Business Research Company | PRODUCT CODE: 1484961
Cryochambers are therapeutic devices or facilities specifically engineered to subject the human body to exceptionally low temperatures for brief durations, aiming to achieve therapeutic objectives. These chambers employ cryotherapy techniques to stimulate physiological responses, which in turn promote a range of health benefits, including muscle recovery, pain management, and improvements in overall well-being.
The primary types of cryochamber markets consist of individual units, also known as cryosaunas, and multiple-person units, often referred to as cryochambers. Individual units, such as cryosaunas, are compact chambers designed for single-person use during cryotherapy sessions. These units are commonly utilized in various applications including fitness centers, beauty spas, cryotherapy centers, sports clubs, and athlete associations, offering therapies such as cryosurgery, icepack therapy, and chamber therapy.
The cryochambers market research report is one of a series of new reports from The Business Research Company that provides cryochambers market statistics, including the cryochambers industry global market size, regional shares, competitors with a cryochambers market share, detailed cryochambers market segments, market trends and opportunities, and any further data you may need to thrive in the cryochambers industry. This cryochambers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cryochambers market size has grown strongly in recent years. It will grow from $6.70 billion in 2023 to $7.30 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historical period can be attributed to several factors, including increased research and development efforts, widespread adoption within the sports and fitness industry, the growing popularity of cryotherapy, rising demand for non-invasive therapeutic options, and the adoption of cryochambers within the sports and fitness sector.
The cryochambers market size is expected to see strong growth in the next few years. It will grow to $10.46 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The projected growth in the forecast period can be attributed to several key factors, including the expansion into new markets, regulatory support and the establishment of standards, broader applications within the medical field, and increasing demand across sectors such as healthcare, automotive, and consumer electronics, driven by overall economic growth. Major trends expected in the forecast period encompass the integration of artificial intelligence (AI) and Internet of Things (IoT) technologies into cryochamber systems, the emergence of hybrid cryotherapy solutions combining different therapeutic approaches, greater integration and validation of cryotherapy within medical practices, a focus on sustainable practices in manufacturing and operation, an emphasis on enhancing user experience, and an increase in partnerships and collaborations within the industry.
The anticipated rise in sports and fitness injuries is poised to drive the expansion of the cryochambers market in the foreseeable future. Sports and fitness injuries, stemming from participation in physical activities or exercises, are on the uptrend due to factors such as rigorous training regimes, inadequate conditioning, suboptimal technique, equipment-related issues, and environmental factors. Cryotherapy, particularly in cryochambers, has emerged as a favored modality in the rehabilitation protocols of athletes and sports professionals, aiding in injury recovery and facilitating post-training or post-competition recuperation. Cryochamber sessions have shown promise in hastening recovery from sports-related injuries such as strains, sprains, and muscle soreness, enabling athletes to resume training and competitions expeditiously. Notably, according to the National Safety Council (NSC), the number of individuals treated in emergency departments for sports and recreational equipment-related injuries reached 3.6 million in 2022, marking a 12% increase from 2021, underscoring the impetus behind the growth of the cryochambers market.
Prominent players in the cryochambers market are strategically focused on developing innovative products such as electronically-cooled chambers to cater to customers' evolving needs with enhanced functionalities. Electronically-cooled cryochambers, specialized chambers utilized in cryotherapy, leverage electronic mechanisms to generate and sustain cold temperatures within the chamber. For instance, in September 2021, CryoAction, a UK-based cryochamber solutions manufacturer, introduced electronically-cooled whole-body cryotherapy chambers renowned for their enhanced efficiency and cost-effectiveness. These chambers, cooled solely from within, offer faster cooling times and reduced temperature losses between treatments compared to conventional models. Featuring meager running costs and the capability to operate for extended durations with automated cooldown and regeneration cycles, these units offer unparalleled convenience and reliability. Moreover, their versatility allows for precise temperature control, catering to diverse therapeutic needs and ensuring optimal treatment outcomes.
In March 2022, Pietro Fiorentini Group, an Italy-based entity specializing in systems and components for natural gas metering, acquired 60% of the shares of CRYO INOX for an undisclosed sum. This strategic acquisition by Pietro aims to broaden its product portfolio with cutting-edge technological solutions across various industries, enhancing its foothold in critical markets related to energy and sustainability. CRYO INOX, headquartered in Spain, is renowned for manufacturing cryochambers and cryogenic equipment, aligning with Pietro's strategic objectives of technological innovation and market expansion.
Major companies operating in the cryochambers market are Medtronic plc, Stryker Corporation, Air Products And Chemicals, Boston Scientific Corporation, Steris plc, CooperSurgical Inc., DJO LLC, Novotech, Zimmer MedizinSysteme, Pregna International Limited, METRUM CRYOFLEX Sp. z o.o., Mectronic Medicale S.r.l., CryoConcepts LP., Cortex Technology, CryoAction, KrioSystem, JUKA, Impact Cryotherapy, Cryosense, Advanced Monitors Corporation, Brymill Cryogenic Systems, Wallach Surgical Devices, Cryoswiss GmbH, CryoBuilt Inc., CRYO Science, C A Manufacturing Sp zoo, Cryoalfa
North America was the largest region in the cryochambers market in 2023. The regions covered in the cryochambers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cryochambers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cryochambers market consists of revenues earned by entities by providing services such as skin rejuvenation, boosting metabolism, and whole-body cryotherapy (WBC). The market value includes the value of related goods sold by the service provider or included within the service offering. The cryochambers market includes sales of cryotherapy equipment, protective gear, and therapeutic tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.